Oncolytics Biotech, Inc. (ONCY)
0.488
+0.01
(+3.11%)
USD |
NASDAQ |
Oct 13, 14:04
Oncolytics Biotech Total Return Level : 0.4733 for Oct. 12, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 12, 2026 | 0.4733 |
| October 09, 2026 | 0.557 |
| October 08, 2026 | 0.5444 |
| October 07, 2026 | 0.5958 |
| October 06, 2026 | 0.598 |
| October 05, 2026 | 0.5969 |
| October 02, 2026 | 0.631 |
| October 01, 2026 | 0.6412 |
| September 30, 2026 | 0.6682 |
| September 29, 2026 | 0.6745 |
| September 28, 2026 | 0.663 |
| September 25, 2026 | 0.6833 |
| September 24, 2026 | 0.6792 |
| September 23, 2026 | 0.6765 |
| September 22, 2026 | 0.7133 |
| September 21, 2026 | 0.7663 |
| September 18, 2026 | 0.77 |
| September 17, 2026 | 0.77 |
| September 16, 2026 | 0.7688 |
| September 15, 2026 | 0.78 |
| September 14, 2026 | 0.8127 |
| September 11, 2026 | 0.7455 |
| September 10, 2026 | 0.772 |
| September 09, 2026 | 0.795 |
| September 08, 2026 | 0.805 |
| Date | Value |
|---|---|
| September 04, 2026 | 0.8432 |
| September 03, 2026 | 0.8565 |
| September 02, 2026 | 0.88 |
| September 01, 2026 | 0.84 |
| August 31, 2026 | 0.8382 |
| August 28, 2026 | 0.8566 |
| August 27, 2026 | 0.85 |
| August 26, 2026 | 0.8556 |
| August 25, 2026 | 0.8614 |
| August 24, 2026 | 0.8441 |
| August 21, 2026 | 0.8431 |
| August 20, 2026 | 0.8017 |
| August 19, 2026 | 0.831 |
| August 18, 2026 | 0.8448 |
| August 17, 2026 | 0.8227 |
| August 14, 2026 | 0.834 |
| August 13, 2026 | 0.80 |
| August 12, 2026 | 0.8237 |
| August 11, 2026 | 0.82 |
| August 10, 2026 | 0.8028 |
| August 07, 2026 | 0.8025 |
| August 06, 2026 | 0.8006 |
| August 05, 2026 | 0.7972 |
| August 04, 2026 | 0.8105 |
| August 03, 2026 | 0.775 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 60.73 |
| Sangamo Therapeutics, Inc. | 0.15 |
| Sarepta Therapeutics, Inc. | 17.44 |
| Anixa Biosciences, Inc. | 2.84 |
| Mera Pharmaceuticals, Inc. | 0.0001 |